SARS-CoV2 Infection

Showing 1 - 25 of 107

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

SARS-CoV2 Infection Trial in Flint (General SARS-CoV-2 Communication, Rural-Targeted SARS-CoV-2 Communication)

Recruiting
  • SARS-CoV2 Infection
  • General SARS-CoV-2 Communication
  • Rural-Targeted SARS-CoV-2 Communication
  • Flint, Michigan
    Flint Journal Building
Oct 10, 2023

Post COVID-19 Condition, Unspecified, SARS-CoV2 Infection, COVID-19 Trial (Nirmatrelvir/ritonavir, Placebo)

Not yet recruiting
  • Post COVID-19 Condition, Unspecified
  • +2 more
  • (no location specified)
May 9, 2023

SARS-CoV2 Infection Trial in Larissa (Hypertonic seawater solution)

Completed
  • SARS-CoV2 Infection
  • Hypertonic seawater solution
  • Larissa, Thessaly, Greece
    University Hospital of Larissa
Feb 15, 2023

Covid19, Covid19 Drug Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Bobo-Dioulasso, Conakry (Nitazoxanide

Recruiting
  • Covid19
  • +3 more
  • Nitazoxanide and Ciclésonide
  • +3 more
  • Bobo-Dioulasso, Burkina Faso
  • +1 more
Jan 30, 2023

SARS-CoV2 Infection Trial in Renton (HDT-301)

Active, not recruiting
  • SARS-CoV2 Infection
  • HDT-301
  • Renton, Washington
    Rainier Clinical Research
Jan 16, 2023

Post Acute COVID-19 Syndrome, Long COVID, Long Covid19 Trial in New York (stellate ganglion block with 0.5% bupivacaine)

Recruiting
  • Post Acute COVID-19 Syndrome
  • +14 more
  • stellate ganglion block with 0.5% bupivacaine
  • New York, New York
    Hudson Medical
Jan 10, 2023

SARS-CoV2 Infection, Covid19, SARS-CoV-2 Acute Respiratory Disease Trial in Worldwide (BNT162b2, BNT162b2 (B.1.1.7 + B.1.617.2),

Active, not recruiting
  • SARS-CoV2 Infection
  • +3 more
  • BNT162b2
  • +5 more
  • Long Beach, California
  • +34 more
Jan 10, 2023

COVID-19, SARS-CoV2 Infection, Coronavirus Infection Trial in Worldwide (Fostamatinib, Placebo)

Recruiting
  • COVID-19
  • +2 more
  • Porto Alegre, Brazil
  • +20 more
Jan 6, 2023

SARS-CoV-2 Vaccine Tolerability and Clinical Outcome Among

Completed
  • SARS-CoV2 Infection
  • +3 more
  • IM injection of vaccination (mRNA vaccination)
  • IM injection of vaccination (vector based vaccination)
  • Hildesheim, Niedersachsen, Germany
    Helios Hospital Hildesheim
Dec 29, 2022

SARS-CoV2 Infection, Covid19 Trial (Low-dose acetylsalicylic acid, Placebo)

Recruiting
  • SARS-CoV2 Infection
  • Covid19
  • Low-dose acetylsalicylic acid
  • Placebo
  • Maputo, Mozambique
  • +3 more
Dec 16, 2022

SARS-CoV2 Infection Trial in Newark (Testing for SARS CoV2 Antigen and Antibody)

Active, not recruiting
  • SARS-CoV2 Infection
  • Testing for SARS CoV2 Antigen and Antibody
  • Newark, New Jersey
    Rutgers School of Dental Medicine
Nov 5, 2022

SARS-CoV2 Infection Trial in Newark (Testing for SARS CoV2 RNA)

Completed
  • SARS-CoV2 Infection
  • Testing for SARS CoV2 RNA
  • Newark, New Jersey
    Rutgers School of Dental Medicine
Nov 5, 2022

SARS-CoV2 Infection, COVID-19 Trial in United States (iCura COVID-19 Antigen Rapid Home Test, RT-PCR Test)

Completed
  • SARS-CoV2 Infection
  • COVID-19
  • iCura COVID-19 Antigen Rapid Home Test
  • RT-PCR Test
  • DeLand, Florida
  • +3 more
Oct 14, 2022

COVID-19, SARS-CoV2 Infection Trial in New Haven (Neosporin, Vaseline)

Recruiting
  • COVID-19
  • SARS-CoV2 Infection
  • New Haven, Connecticut
    Yale University
Sep 12, 2022

SARS-CoV2 Infection Trial in India (COVAXIN)

Completed
  • SARS-CoV2 Infection
  • COVAXIN
  • Visakhapatnam, Andhra Pradesh, India
  • +6 more
Aug 17, 2022

SARS-CoV2 Infection, COVID-19 Trial in Long Beach, Miami Lakes, New York (IMM-BCP-01, Placebo)

Recruiting
  • SARS-CoV2 Infection
  • COVID-19
  • Long Beach, California
  • +2 more
Aug 11, 2022

SARS-COV-2/COVID-19 Neutralizing Antibodies in Blood

Completed
  • SARS-CoV2 Infection
    • Starkville, Mississippi
    • +4 more
    Aug 8, 2022

    Lipids in SARS-CoV2 Infection - In Search of Atherogenic

    Recruiting
    • SARS-CoV2 Infection
    • Blood sample of 30 ml
    • Dijon, France
      Chu Dijon Bourgogne
    Jul 25, 2022

    COVID-19 Pandemic on Allogeneic Stem Cell Transplantation

    Completed
    • Allogeneic Stem Cell Transplantation
    • +2 more
      • Vandoeuvre Les Nancy, Meurthe-et-Moselle, France
        CHRU of Nancy
      Jul 19, 2022

      2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial in United States (Famotidine,

      Terminated
      • 2019 Novel Coronavirus Disease
      • +11 more
      • Newport Beach, California
      • +14 more
      Jul 20, 2022

      COVID-19, SARS-CoV2 Infection Trial (Novel point-of-care, semi-quantitative test for SARS-CoV-2 antibodies)

      Not yet recruiting
      • COVID-19
      • SARS-CoV2 Infection
      • Novel point-of-care, semi-quantitative test for SARS-CoV-2 antibodies
      • (no location specified)
      Jul 14, 2022

      MISC COVID-19 Study in Pediatric Population

      Recruiting
      • SARS-CoV2 Infection
      • Multisystem Inflammatory Syndrome in Children
        • Chennai, Tamilnadu, India
          National Institute for Research in Tuberculosis
        Jul 7, 2022

        SARS-CoV2 Infection, Coronavirus Infection Trial in Hamilton (mRNA- COVID-19, Prevnar13)

        Not yet recruiting
        • SARS-CoV2 Infection
        • Coronavirus Infection
        • Hamilton, Ontario, Canada
          McMaster University
        Jun 29, 2022

        Covid19, SARS-CoV2 Infection, Coronavirus Disease 2019 Trial in France, Russian Federation, South Africa (Masitinib Mesylate,

        Recruiting
        • Covid19
        • +2 more
        • Masitinib Mesylate
        • Placebo
        • Clermont-Ferrand, France
        • +5 more
        Jun 22, 2022

        COVID-19 Immunogenicity ofThird Dose of mRNA-1273 Vaccine Among

        Active, not recruiting
        • Covid19
        • SARS-CoV2 Infection
        • mRNA-1273
        • Tampa, Florida
          Moffitt Cancer Center
        Jun 20, 2022